What explains the volatility in AstraZeneca's net profit throughout 2022?

The volatility in AstraZeneca's net profit throughout 2022 can be attributed to several factors: 1. **Impairment Losses**: AstraZeneca reported impairment losses of $4.68 billion in 2022. These losses are a result of the company's strategy to divest certain assets and businesses, which can significantly impact net profit. 2. **Financial Expenses**: The company also reported financial expenses of $1.5 billion in the same period. Financial expenses can be volatile due to factors such as changes in interest rates, exchange rates, or the company's financial restructuring. In conclusion, the volatility in AstraZeneca's net profit in 2022 is primarily due to the impairment losses and financial expenses. These factors are related to the company's strategic decisions and financial management, which can fluctuate from year to year.